LifeStance generated fourth quarter 2025 revenue of 382200000, up 17% year-over-year, driven by 18% growth in visit volumes and clinician expansion to 8040. Net income was 11700000 and Adjusted EBITDA increased 49% to 48800000, reflecting operating leverage and margin expansion.
Revenue increased 17% year-over-year to 382200000.
Visit volumes grew 18% to 2400000, supported by clinician growth.
Net income improved to 11700000 from a prior-year loss.
Adjusted EBITDA rose 49% to 48800000 with margin expanding to 12.8%.
For full year 2026, LifeStance expects revenue of 1615000000 to 1655000000, Center Margin of 526000000 to 550000000, and Adjusted EBITDA of 185000000 to 205000000.
Analyze how earnings announcements historically affect stock price performance